Flatley Discovery Lab, LLC Company Profile

10:56 EDT 23rd March 2018 | BioPortfolio

News Articles [308 Associated News Articles listed on BioPortfolio]

Illumina’s Jay Flatley: In “Shock and Awe” at State of Personalized Medicine

Illumina executive chairman Jay Flatley was honored with the Lifetime Achievement Award at the annual Personalized Medicine Conference on November 15, 2017, in Boston, MA. Flatley was introduced b...

Illumina, Inc. (ILMN) Director Jay T. Flatley Sells 20,000 Shares

Illumina, Inc. Director Jay T. Flatley sold 20,000 shares of the business's stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $212.55, for a total trans...

Blue Oak and PsychoGenics partner on drug discovery

Blue Oak Pharmaceuticals and PGI Drug Discovery have entered into a partnership to discover and optimize novel treatments for brain disorders and psychiatric conditions. Under the terms of the agreeme...

BRIEF—UK’s Medicines Discovery Catapult in new AMR project

The Medicines Discovery Catapult, the UK government-backed body that seeks to speed drug discovery and…

How Robot Math and Smartphones Led Researchers to a Drug Discovery Breakthrough

NewsResearchers have figured out how to apply an algorithm originally designed to help robots move to an entirely different problem: drug discovery.

Beacon Discovery, Janssen team up in metabolic conditions

Beacon Discovery Inc. and Janssen Pharmaceuticals Inc. are teaming up in the discovery of small molecules aimed at various G-protein coupled receptor (GPCR) targets for metabolic diseases.

X-Chem, AstraZeneca expand drug discovery partnership

X-Chem, a small molecule discovery specialist, has expanded its existing global drug discovery and technology transfer collaboration with AstraZeneca.

The Current issue of “The view from here” is concerned with nanoscience in drug discovery.

The topic of this month’s newsletter from Drug Discovery Today is “nanoscience in drug discovery”

PubMed Articles [543 Associated PubMed Articles listed on BioPortfolio]

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

Machine intelligence, which is normally presented as artificial intelligence, refers to the intelligence exhibited by computers. In the history of rational drug discovery, various machine intelligence...

Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors.

Phosphodiesterases are proving to be fruitful targets for drug discovery. At the same time fragment-based drug discovery has matured into a powerful and widely applied technique. In this communication...

Allosteric Tuning of Caspase-7: a Fragment-Based Drug Discovery Approach.

The caspase family of cysteine proteases are highly sought after drug targets due to their essential roles in apoptosis, proliferation and inflammation pathways. High throughput screening efforts to d...

Challenges with modelling anxiety disorders: a possible hindrance for drug discovery.

Clinical Trials [162 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1082 Associated Companies listed on BioPortfolio]

Flatley Discovery Lab, LLC

Sepsis Alliance

Sepsis Alliance is a nonprofit patient advocacy organization in the U.S. promoting awareness of sepsis. Sepsis Alliance operates by providing information and education to raise aw...

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including, as well as its Continuing Medical Education (CME) business and ...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and ...

More Information about "Flatley Discovery Lab, LLC" on BioPortfolio

We have published hundreds of Flatley Discovery Lab, LLC news stories on BioPortfolio along with dozens of Flatley Discovery Lab, LLC Clinical Trials and PubMed Articles about Flatley Discovery Lab, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Flatley Discovery Lab, LLC Companies in our database. You can also find out about relevant Flatley Discovery Lab, LLC Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record